Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03079882 · ClinicalTrials.gov registry record
VisR Ultrasound for Noninvasively Monitoring Renal Allograft Health
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 65
- Enrollment target
NCT03079882 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 65 participants.
The verdict
NCT03079882 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 65 participants
- Enrollment target
Study Summary
Ten percent of American adults, more than 20 million people, have chronic kidney disease, which in the advanced state of end stage renal disease is most desirably and cost-effectively treated by kidney transplantation. However, 20-30% of transplanted kidneys fail in living recipients by 10 years, owing largely to insufficient monitoring methods. The goal of the proposed research is to improve noninvasive kidney transplant monitoring using a new ultrasound-based imaging method called Viscoelastic Response (VisR) ultrasound.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2016-06-16 |
| Est. Completion | 2021-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03079882
The ClinicalTrials.gov registry entry for NCT03079882 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03079882 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03079882 about?
NCT03079882 is a clinical study titled "VisR Ultrasound for Noninvasively Monitoring Renal Allograft Health". Ten percent of American adults, more than 20 million people, have chronic kidney disease, which in the advanced state of end stage renal disease is most desirably and cost-effectively treated by kidney transplantation. However, 20-30% of transplanted kidneys fail in living recipients by 10 years, ow...
What is the current status of trial NCT03079882?
This trial is currently completed. The enrollment target is 65 participants. The study started on 2016-06-16. Estimated completion is 2021-02-28.
Who is sponsoring clinical trial NCT03079882?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.